Table 1 Patients characteristics
From: Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing
|  | Frozen Cytology Pellet (n = 75) | Frozen Tissue (n = 57) | ORR (95%CI) | P value |
|---|---|---|---|---|
Age-Median [IQR] | 72 [65.5–76] | 71 [66–74] |  | 0.47 |
male/female | 58/17 | 43/14 | 0.9 (0.37–2.21) | 0.84 |
Brinkman Index Median [IQR] | 900 [440–1210] | 940 [570–1060] |  | 0.69 |
primary tumor size(mm) Median [IQR] | 35 [25–46] | 50 [35–63] |  |  < 0.01 |
Stage | Â | Â | Â | 0.08 |
 II | 3 (4.0%) | 9 (15.8%) |  |  |
 III | 32 (42.7%) | 17 (29.8%) |  |  |
 IV | 38 (50.6%) | 29 (50.9%) |  |  |
Recurrent | 2 (2.7%) | 2 (3.5%) | Â | Â |
Histology | Â | Â | Â | 0.37 |
 Adeno | 39 (52.0%) | 27 (47.4%) |  |  |
 Sq | 17 (22.6%) | 21 (36.8%) |  |  |
 NOS | 9 (12.0%) | 4 (7.0%) |  |  |
 SCLC | 9 (12.0%) | 5 (8.8%) |  |  |
 LCNEC | 1 (1.4%) | 0 |  |  |
Procedure |  |  |  |  < 0.01 |
 EBUS-TBNA | 31 (41.3%) | 3 (5.3%) |  |  |
 TBB (ultrathin) | 1 (1.4%) | 1 (1.7%) |  |  |
 EBUS-GS-TBB (thin) | 27 (36.0%) | 21 (36.8%) |  |  |
 EBUS-GS-TBB (thick) | 4 (5.3%) | 11 (19.3%) |  |  |
 EBB | 10 (13.3%) | 18 (31.6%) |  |  |
 TBB under X-ray fluoroscopy | 2 (2.7%) | 3 (5.3%) |  |  |